Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Descriptive analysis and Comparison of Secondary Outcomes

From: Preoperative moderate thrombocytopenia is not associated with increased blood loss for low-risk cesarean section: a retrospective cohort study

VariableThrombocytopenic Group (n = 155)Control Group (n = 310)Estimate (OR or mean difference)95% CIp value
Blood transfusion5 (3.2%)7 (2.3%)1.550.43–5.580.505
Visually estimated blood loss315.8 ± 150.0297.6 ± 126.618.23−7.07-43.520.158
Hemostatic therapy0 (0%)0 (0%)///
Adverse event2 (1.3%)2 (0.65%)2.000.28–14.200.488
ICU stay12 (7.7%)2 (0.65%)12.002.69–53.620.001a
Length of hospital stay3 [3,4]3 [3,4]0.400.09–0.710.011a
All-cause mortality0 (0%)0 (0%)///
  1. Abbreviations: ICU intensive care unit, OR odds ratio, CI confidence interval;
  2. Continuous data was expressed as mean (SD) (normally distributed data) or median (quartiles) (non-normally distributed data. Categorical data was expressed as number (percentage). Visually estimated blood loss and the length of postoperative hospital stay was compared by mixed-effect model. Other parameters were compared by conditional logistic regression. a Significant difference